Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, 361-763, Korea.
Surg Endosc. 2021 Jun;35(6):2846-2854. doi: 10.1007/s00464-020-07720-3. Epub 2020 Jun 15.
The clinical pathway (CP) protocols simplified a systematic process from hospitalization to discharge, and were conducted to achieve standardization of the treatment process as well as improve outcomes. Thus, we investigated the optimal procedure-related hospitalization period following gastric endoscopic submucosal dissection (ESD) by comparing the rate of delayed bleeding (DB) and perforation according to CP protocols.
We retrospectively enrolled 630 patients who underwent ESD for gastric dysplasia or early gastric cancer (EGC); Group A (368 patients) followed Protocol A for a hospital stay of a single night; Group B (262 patients) followed Protocol B for a hospital stay of two nights.
The patient characteristics were comparable between the two groups, except for pathologic diagnosis (42.1% in Group A vs. 32.1% in Group B for EGC). DB occurred in 21 patients, and there was no significant difference in the overall DB rates between Group A (12/368 = 3.3%) and Group B (9/262 = 3.4%) (P = 0.904). The DB rates were 2.5% (8/315) and 7.5% (4/53) in Group A, and 2.7% (6/223) and 7.7% (3/39) in Group B, without and with the use of antiplatelets, respectively, and 33.3% (1/3) in Group A and 50.0% (1/2) in Group B with the use of dual antiplatelets. DB developed at various intervals post-discharge from 2 to 17 days, and was successfully controlled by endoscopic hemostasis in most cases. There were no deaths or surgeries required as a result of uncontrolled DB and no postoperative delayed perforation occurred.
The CP protocols with a one-night hospitalization following gastric ESD decreased the hospital stay and did not influence postoperative complications compared to those with two-night hospitalizations.
临床路径(CP)方案简化了从住院到出院的系统流程,旨在实现治疗过程的标准化并改善治疗效果。因此,我们通过比较 CP 方案下接受胃内镜黏膜下剥离术(ESD)患者的延迟性出血(DB)和穿孔发生率,来探讨术后最佳的住院时间。
我们回顾性纳入了 630 例行 ESD 治疗的胃黏膜病变或早期胃癌(EGC)患者;A 组(368 例)患者采用单夜住院方案(住院 1 晚),B 组(262 例)采用双夜住院方案。
两组患者的一般资料无显著差异,除了病理诊断(A 组中 EGC 患者占 42.1%,B 组中占 32.1%)。A、B 两组患者 DB 总发生率分别为 12/368(3.3%)和 9/262(3.4%),差异无统计学意义(P=0.904)。A 组中未使用抗血小板药物和使用抗血小板药物的患者 DB 发生率分别为 2.5%(8/315)和 7.5%(4/53),B 组中未使用抗血小板药物和使用抗血小板药物的患者 DB 发生率分别为 2.7%(6/223)和 7.7%(3/39)。两组患者 DB 均发生在出院后 2-17 天,大多数通过内镜止血成功控制。A 组中有 1 例(33.3%)和 B 组中有 1 例(50.0%)患者因双联抗血小板药物的使用导致 DB 无法控制,后改行介入治疗。无患者因 DB 发生死亡或需要手术,亦无术后迟发性穿孔发生。
与双夜住院方案相比,接受胃 ESD 治疗的患者采用单夜住院 CP 方案可减少住院时间,且不影响术后并发症的发生。